Register for our free email digests:
Latest From Eiken Chemical Co. Ltd.
A new draft guidance from the National Institute for Health and Care Excellence (NICE) recommends the NHS use fecal immunochemical tests (FITs), instead of guaiac-based tests, for detecting gastrointestinal bleeding associated with bowel cancer.
Emerging Irish IVD company HiberGene Diagnostics has just CE marked HG Meningococcus, a molecular diagnostic test for bacterial meningitis that can detect Neisseria meningitidis in cerebrospinal fluid, whole blood and via a nasopharyngeal swab in less than one hour. The company is set to launch the test in Europe with distribution agreements in place for Ireland, Germany, Austria, Spain, Turkey and Poland.
Dublin-based start-up HiberGene Diagnostics Ltd. aims to create rapid, accurate, and simple diagnostic tests for infectious diseases based on LAMP (loop-mediated isothermal amplification) technology, which uses nucleic acid amplification to identify target genes.
Six quality-related FDA close-out letters were released from Aug. 12 through Sept. 11.
- Drug Delivery
- Specialty Pharmaceuticals
- Therapeutic Areas
- Infectious & Viral Diseases
- North America
- Parent & Subsidiaries
- Novavax Inc.
- Senior Management
Stanley C Erck, Pres. & CEO
Barclay A Phillips, SVP, CFO
Gregory M Glenn, MD, Pres., R&D
Russell P Wilson, SVP, Bus. Dev.
John J Trizzino, SVP, Commercial Ops.
James F Cummings, MD, VP, Clinical Dev. & Translational Medicine
- Contact Info
Phone: (240) 268-2000
20 Firstfield Rd.
Gaithersburg, MD 20878
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.